ArticleMedComm2026

Efficacy and Safety of Benmelstobart Plus Anlotinib in Advanced Endometrial Cancer: Results of a Multi-Cohort, Phase II Study (ETER200).

Shanhui Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.